HFCAS OpenIR

Browse/Search Results:  1-10 of 25 Help

Selected(0)Clear Items/Page:    Sort:
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
Authors:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi;  Yu, Chang;  Li, Guangliang;  Wang, Xiaojia;  Shao, Xiying
Favorite  |  View/Download:37/0  |  Submit date:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report  
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
Authors:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui;  Wang, Dewei;  Ran, Li;  Sun, Tao;  Zhao, Da;  Bai, Yuju;  Yang, Shun'e;  Wang, Xiaojia;  Wu, Rong;  Zeng, Xiaohua;  Yao, Herui;  Ji, Xuening;  Jiang, Jun;  Hu, Xiaohua;  Lin, Haifeng;  Zheng, Liping;  Zhu, Zhitu;  Ge, Wei;  Yang, Junlan;  Cui, Tongjian;  Zhang, Xiaozhi;  Lu, Fangyang;  Li, Wenhui;  Xu, Hongyan;  Kang, Mafei;  Gong, Ping;  Zou, Liqun;  Liu, Jiang;  Zhang, Hongliang;  Yu, Hao;  Xu, Binghe
Favorite  |  View/Download:50/0  |  Submit date:2022/12/23
breast cancer  chemotherapy  efficacy  lobaplatin  neoplasm metastasis  safety  
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
Authors:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo;  Wang, Qian;  Liu, Aijun;  Yu, Jinpu;  Fang, Wenfeng;  Zhong, Wenzhao;  Wang, Zhijie;  Zhang, Yongchang;  Liu, Jingjing;  Zhang, Shirong;  Cai, Xiuyu;  Liu, Anwen;  Li, Wen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Lin, Rongbo;  Liu, Weifeng;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Lei, Lei;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Zhang, Junping;  Xue, Junli;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Hu, Xiao;  Zhou, Jin;  Zhu, Zhengfei;  Li, Yongheng;  Qiu, Hong;  Xia, Fan;  Lu, Yuanyuan;  Chen, Xiaofeng;  Ge, Rui;  Dai, Enyong;  Han, Yu;  Pan, Weiwei;  Luo, Jiancheng;  Jia, Hongtao;  Dong, Xiaowei;  Pang, Fei;  Wang, Kai;  Wang, Liping;  Zhu, Youcai;  Xie, Yanru;  Lin, Xinqin;  Cai, Jing;  Wei, Jia;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Du, Yingying;  Yao, Wang;  Shi, Xuefei;  Niu, Xiaomin;  Yuan, Dongmei;  Yao, Yanwen;  Huang, Jianhui;  Zhang, Yinbin;  Sun, Pingli;  Wang, Hong;  Ye, Mingxiang;  Wang, Dong;  Wang, Zhaofeng;  Wan, Bing;  Lv, Donglai;  Wei, Qing;  Kang, Jin;  Zhang, Jiatao;  Zhang, Chao;  Yu, Genhua;  Ou, Juanjuan;  Shi, Lin;  Li, Zhongwu;  Liu, Zhefeng;  Liu, Jing;  Yang, Nong;  Wu, Lin;  Wang, Huijuan;  Jin, Gu;  Yang, Liu;  Wang, Guansong;  Fang, Meiyu;  Fang, Yong;  Li, Yuan;  Wang, Xiaojia;  Zhang, Yiping;  Ma, Shenglin;  Wang, Biyun;  Zhang, Xiaotian;  Song, Yong;  Lu, Yuanzhi
Favorite  |  View/Download:48/0  |  Submit date:2022/12/22
fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase  
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer 期刊论文
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 卷号: 21
Authors:  Chen, Keyu;  Wu, Jiayi;  Fang, Ziru;  Shao, Xiying;  Wang, Xiaojia
Favorite  |  View/Download:31/0  |  Submit date:2022/12/22
early-stage breast cancer  genomic expression profiles  Oncotype DX  MammaPrint  RecurIndex  prediction tools  
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
Authors:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia
Favorite  |  View/Download:29/0  |  Submit date:2022/12/23
Breast cancer  nanoparticle-albumin-bound paclitaxel (Nab-P)  taxanes  meta-analysis  
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
Authors:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying;  Cao, Wenming;  Chen, Junqing;  Ye, Weiwu;  Ping, Huang;  Li, Guangliang;  Lei, Lei;  Shi, Lei;  Huang, Yuan;  Zou, Weibin;  Wang, Rong;  Shen, Xia-Bo;  Lou, Caijin
Favorite  |  View/Download:30/0  |  Submit date:2022/12/23
BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
Authors:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong;  Pan, Jiani;  Ye, Weiwu;  Chen, Zhanhong;  Zheng, Yabing;  Shao, Xiying;  Xu, Yuanji
Favorite  |  View/Download:36/0  |  Submit date:2022/12/23
Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
Authors:  Cao, Wen-Ming;  Pan, Jiani;  Wang, Xiaojia;  Lou, Feng;  Li, Mingwei;  Wang, Meng;  Wang, Rong;  Ye, Weiwu
Favorite  |  View/Download:27/0  |  Submit date:2022/12/23
Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
Authors:  Fang, Zi-Ru;  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Shao, Xi-Ying;  Wang, Xiaojia
Favorite  |  View/Download:41/0  |  Submit date:2022/12/23
Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
Authors:  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Fang, Zi-Ru;  Li, Guang-Liang;  Zou, Wei-Bin;  Wang, Xiaojia;  Shao, Xi-Ying
Favorite  |  View/Download:29/0  |  Submit date:2022/12/23